Iris Biotech

Executive Summary

Iris Biotech is a German manufacturer and supplier of high-purity peptides, amino acid derivatives, and specialized biochemicals, serving the global research and pharmaceutical development sectors. Founded in 1992 and headquartered in Marktredwitz, Germany, the company operates as a B2B provider of critical building blocks for drug discovery and proteomics applications. With a reputation for quality and reliability, Iris Biotech has established a stable niche in the life sciences supply chain, catering to academic and industrial customers worldwide. The company's focus on high-purity products positions it favorably for continued demand from the growing peptide therapeutics market, though its role as a supplier rather than an innovator means growth is tied to overall industry trends rather than proprietary pipeline events.

Upcoming Catalysts (preview)

• Q4 2026Expansion of peptide production capacity70% success
• Q1 2027New strategic partnerships with pharma companies50% success
• Q2 2026Launch of novel amino acid derivatives portfolio60% success